M&L Healthcare's First MedTech Investment Receives FDA Approval Following Successful US Trials

Revolutionary limb saving procedure set to benefit patients with Chronic Limb-Threatening Ischemia, typically caused by Type 2 DiabetesSINGAPORE - Media OutReach - 15 September...

Related Keywords

United States ,Singapore ,Paris ,France General ,France ,United Kingdom ,Germany ,Changi ,Singapore General ,M Lhealthcare Limflow Medtech ,Steven Kum ,Asia Pacific ,Roberto Ferraresi ,Jocelyn Kum ,Tim Lenihan ,Vascular Team In Changi ,Rml Group ,Limflow Medical Technology ,Drug Administration ,Chronic Limb Threatening Ischemia ,Limflow System ,New England Journal ,Transcatheter Arterialization ,Deep Veins ,Chief Medical Officer ,Vascular Surgeon ,Vascular Team ,Changi General Hospital ,Executive Director ,Deep Venous Arterialization ,Crossing Catheters ,Breakthrough Designation ,Singapore Based Kum ,Chief Medical ,M Amp L ,Healthcare 039 S ,First ,Medtech ,Investment ,Receives ,Fda ,Approval ,Following ,Successful ,Us ,Trials ,